Actively Recruiting
European Registry Study on Real-World Treatment and Outcomes in Advanced Basal Cell and Cutaneous Squamous Cell Carcinoma
Led by EuMelaReg gGmbH · Updated on 2025-03-12
1300
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying advanced non-melanoma skin cancer NMSC, including basal cell carcinoma BCC and cutaneous squamous cell carcinoma cSCC, through a European registry that collects real-world data. The study aims to understand disease characteristics, treatment patterns, and outcomes in patients with advanced or high-risk cSCC across different European regions. This registry-based observational study gathers data independent of specific treatments used in routine clinical practice. The study includes three patient groups those with resected high-risk cSCC receiving postoperative radiotherapy or watchful waiting, patients with advanced cSCC not eligible for curative surgery or radiation, and patients with advanced BCC also not candidates for curative treatments. Data from these groups are collected through the European NMSC registry, which integrates national registries and maintains quality and data protection standards. Participants contribute data over a period ranging from a minimum of two years up to five years. Researchers assess demographics, tumor characteristics, treatment patterns, survival rates, adverse drug reactions, disease progression times, and recurrence rates. Data quality is managed through validation plans, and information is verified for accuracy and completeness. The study provides valuable insights into the management and outcomes of advanced NMSC patients in real-world clinical settings.
CONDITIONS
Brief Title
Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC
Research Team
A
Alexandra Hansen
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here